Clinical outcomes of adults with type 1 diabetes and comorbid depression and/or anxiety disorders using hybrid closed‐loop: A retrospective study from a multidisciplinary tertiary centre
HCL users demonstrated improved HbA<sub>1c</sub> and TIR, compared with non-HCL users. These real-world data support safe use of HCL in people with type 1 diabetes and depression/anxiety in a multidisciplinary setting. Qualitative studies and prospective trials are required to further evaluate the impact of HCL on biomedical and mental health outcomes.
Authors
- Aditi Shrestha (ORCID: https://orcid.org/0009-0008-6892-5452)
- Miranda Rosenthal
- Geraldine Gallen
- Yee Seun Cheah
- Adam Kia Shooshtarian
- Anusha Ahuja
- Marilia Calcia
- Ben Stotesbury
- Rachael J. L. Tan (ORCID: https://orcid.org/0000-0003-4013-6810)
- Jonathan Croos
- Marietta Stadler
- Khalida Ismail
Institutions
- King's College London (GB)
- King's College Hospital NHS Foundation Trust (GB)
- King's College School (GB)
- Diabetes UK (GB)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-01-20
- DOI
- https://doi.org/10.1111/dom.70432
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00